Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01D
- Chemical subgroupL01DB
- Chemical substanceL01DB07Mitoxantrone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 11 registrations
- EvomixanFarmarin Industria e Comercio Ltda
- EvomixanHospira Produtos Hospitalares Ltda
- EvomixanEvolabis Produtos Farmacêuticos Ltda
- EvomixanPfizer Brasil Ltda
Canada
Health Canada · 5 registrations
At a glance
- ATC code
- L01DB07
- Registers
- 6
- Historical lists
- 2
- Registrations
- 29
- With their own page
- 7
- Companies
- 26
All medicines with Mitoxantrone
Human medicines from every register that match Mitoxantrone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
30 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Mitoxantrone Hydrochloride | United States | 20MG BASE/10ML, 25MG BASE/12.5ML, 30MG BASE/15ML | injectable | Marketed | Fresenius Kabi Oncol |
| Mitoxantrone Injection | Canada | 2 MG / ML | Solution | Marketed | Fresenius Kabi Canada LTD |
| MITOXANTRONE BAXTER INJECTION 2 mg/ml | Singapore | 2 mg/ml | injection | Authorised | Baxter Healthcare (Asia) Pte LTD |
| Novantrone | United States | 20MG BASE/10ML, 25MG BASE/12.5ML, 2MG BASE/ML … | injectable | Not marketed | Serono INC |
| Mitoxantron Accord 2 mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Accord Healthcare B.V. | |
| Mitoxantron Sandoz 2 mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Sandoz B.V. | |
| Evomixan | Brazil | Authorised | Farmarin Industria e Comercio Ltda | ||
| Mitoxantron Ebewe 2MG-1ML Sol. for Infu | Saudi Arabia | Authorised | Fareva Unterach GmbH | ||
| Novantrone Vial 2MG-ML | Saudi Arabia | Authorised | Lederle | ||
| Novantrone Vial 2MG-ML | Saudi Arabia | Authorised | Lederle | ||
| Novantrone Vial 2MG-ML | Saudi Arabia | Authorised | Lederle | ||
| Mitoxantrone Injection | Canada | 2 MG / ML | Solution | Cancelled | Teva Canada Limited |
| Mitoxantrone Injection USP | Canada | 2 MG / ML | Solution | Cancelled | Pfizer Canada Ulc |
| Toxantrona | Brazil | Cancelled | Produtos Farmacêuticos Gunther do Brasil Ltda | ||
| Mitoxal | Brazil | Cancelled | Asta Médica-Oncologia Ltda | ||
| Mitoxal | Brazil | Cancelled | Asta Médica Ltda | ||
| Novantrone | Canada | 2 MG / ML | Liquid | Cancelled | Wyeth Canada |
| Novantrone | Brazil | Cancelled | Pfizer Brasil Ltda | ||
| MITOXANTRONA SANDOZ 2 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 2,3284 mg | concentrado para solución para perfusión | Withdrawn | Sandoz Farmaceutica S.A. |
| Mitoxantrona Accord 2 MG/ML Concentrado Para Solucion Para Perfusion Efg | Spain | 2,33 mg/ml | concentrado para solución para perfusión | Suspended | Accord Healthcare S.L.U. |
| Novantrone Inj 2MG/ML | Canada | 2 MG / ML | Liquid | Cancelled | Lederle Cyanamid Canada INC. |
| NOVANTRONE 2 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 20 mg | concentrado para solución para perfusión | Suspended | Mylan Ire Healthcare Limited |
| Mitostate | Brazil | Cancelled | Quiral Química do Brasil S/A | ||
| ONKOTRONE 2 mg/ml | Romania | 2mg/ml | conc. pt. sol. inj. | Status unknown | Baxter Oncology GMBH |
| Mitaxis | Brazil | Cancelled | Ítaca Laboratórios Ltda |